课题基金 / 基金详情

apelin/APJ通过内皮细胞ET-1和BKCa促进糖尿病微血管并发症的作用及机制研究

批准号:
32071112
项目类别:
面上项目
资助金额:
58.0 万元
负责人:
曾翔俊
依托单位:
学科分类:
循环与血液生理
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
曾翔俊

项目摘要

结项摘要

曾翔俊的其他基金

相似基金

相关文献

中文摘要
apelin及其受体APJ是除高血糖外参与糖尿病微血管损伤的重要因素。我们已证实,2型糖尿病时内皮细胞APJ表达降低,血液中增加的apelin却可通过增加eNOS影响内皮细胞依赖的血管及肾功能。因此推测,apelin和APJ可能通过各自独立的信号通路影响内皮细胞功能,从而导致血管和肾功能损伤。本研究利用1型和2型糖尿病模型,探讨apelin/APJ导致内皮细胞功能异常,进而影响血管和肾功能的机制;通过内皮细胞APJ基因敲除小鼠,探讨apelin通过APJ非依赖信号影响内皮细胞功能的机制;通过内皮细胞BKCa基因敲入小鼠,探讨BKCa介导的内皮细胞超极化异常是apelin/APJ影响内皮功能的共同通路;通过培养内皮细胞,探讨APJ感受apelin和牵张刺激调控β-arrestin/BKCa(ET-1)信号的机制。最终论证糖尿病时 apelin/APJ导致内皮依赖性血管和肾功能损伤的分子机制。
英文摘要
Besides hyperglycemia, apelin, an adipokine, and its receptor APJ are important potential factors that may be involved in the diabetic microvascular injuries in diabetes. Our works have revealed that apelin which was increased in the blood in type 2 diabetes would affect the vascular and renal functions by increasing eNOS in endothelial cells in spite of the decreased expression of APJ in endothelial cells, which would induce the increasing of renal blood flow and resulted in the diabetic kidney diseases. Therefore it is supposed that apelin and APJ might induce endothelial dysfunction in diabetes via independent pathways, which would lead to the vascular and renal dysfunction in diabetes. In this study, type 1 and type 2 diabetes which displayed different changes of expression for apelin and APJ were adopted to investigate the mechanisms for apelin/APJ in inducing vascular and renal injuries via causing endothelial dysfunction in diabetes; specific endothelial APJ gene knockout mice were adopted to investigate the APJ -dependent and -independent pathways for apelin in inducing endothelial dysfunction; specific endothelial BKCa gene knockin mice were adopted to investigate that dysfunction of endothelial hyperpolarization induced by BKCa was the shared pathway for apelin and APJ in inducing endothelial dysfunction; cultured endothelial cells were adopted to investigate the intracellular signaling pathways(β-arrestin/ BKCa(ET-1))for APJ in endothelial cells activated by apelin and stretch. The final aim of this study is to demonstrate the molecular pathways for changed expression of apelin and APJ in inducing endothelial dysfunction and resulted in diabetic vascular and renal dysfunction in diabetes.
糖尿病肾病早期表现主要为肾脏血液灌注量增加,而apelin及其受体APJ是除高血糖外参与糖尿病微血管损伤的重要因素,能够改变血管收缩舒张功能及内皮细胞通透性。因此我们推测,apelin和APJ通过相关信号通路影响内皮细胞功能,从而影响血管和肾功能损伤。本工作以STZ诱导的糖尿病小鼠作为糖尿病模型;通过内皮细胞APJ基因敲除小鼠探讨apelin通过APJ非依赖信号影响内皮细胞功能的机制;通过BKCa基因敲除小鼠,验证内皮细胞BKCa在apelin/APJ影响肾脏血流中的作用;同时培养肾小球内皮细胞以确认分子机制。结果显示:apelin依赖其内皮细胞受体APJ调控eNOS,进而增加糖尿病小鼠的肾脏血流量;BKCa通道能够促进内皮细胞内eNOS磷酸化同时减少内皮素-1的表达;apelin/PJ通过上调内皮细胞内PI3K/AKT/GSK-3β/Nrf2信号通路激活BKCa通道,来实现对肾脏血流的调控。此外,通过对小鼠血、尿检测及PAS染色、马松染色和天狼星红染色,发现apelin可以改善糖尿病肾小球滤过膜损伤、尿蛋白增加以及肾脏纤维化和肾小球基底膜增厚肾。通过以上研究认为:apelin依赖其内皮细胞受体APJ,通过激活BKCa通道调控相关分子机制来增加肾脏血流量,同时能够改善内皮细胞功能障碍进而减轻肾脏纤维化,抑制糖尿病肾病的发生发展。
apelin 通过改变肾动脉自身调节功能和足细胞结构参与2型糖尿病肾病的发生发展
  • 批准号:
    81270815
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2012
  • 负责人:
    曾翔俊
  • 依托单位:
apelin/APJ系统在糖尿病肾病中的作用及机制研究
  • 批准号:
    30900573
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    19.0万元
  • 批准年份:
    2009
  • 负责人:
    曾翔俊
  • 依托单位:
国内基金
海外基金